Atlas Trials

Who Remain Disease-free

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Who Remain Disease-free

RecordFirmDate
Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy (NCT01805271)UNICANCER2013-03-01

Track Who Remain Disease-free automatically

Every clearance here is in the API, with alerts when new ones post.